Mar 12, 2021

Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman

Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion...

Read more